drugset / Trial / NCT05604599

Intranasal Versus Intravenous Dexmedetomidine for Hypotensive Anesthesia in FESS

NCT05604599 ↗

Phase 4 Completed 60 enrolled Al-Azhar University
RandomizedParallel-groupTriple-blindPrevention

Summary

Intranasal dexmedetomidine provided good pharmacokinetic profile. However, intravenous dexmedetomidine have been used in functional endoscopic sinus surgery for several outcomes, there is lack in studies that had compared the efficacy of intravenous and Intranasal Dexmedetomidine for improving quality of the operative field in functional endoscopic sinus surgery. Therefore, we established this randomized study to compare intranasal dexmedetomidine with intravenous dexmedetomidine improving quality of the operative field in functional endoscopic sinus surgery.

Timeline

Start
2022-11-10
Primary completion
2023-03-05
Completion
2023-03-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.4 ug/kg Intranasal
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intranasal

Indications

No indication recorded.